Product
Bmab1200
1 clinical trial
1 indication
Indication
Chronic Plaque PsoriasisClinical trial
A Randomized, Double-Blind, Parallel Group, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Bmab 1200 and Stelara in Patients With Moderate to Severe Chronic Plaque PsoriasisStatus: Active (not recruiting), Estimated PCD: 2023-01-26